JP2024540008A5 - - Google Patents

Info

Publication number
JP2024540008A5
JP2024540008A5 JP2024525036A JP2024525036A JP2024540008A5 JP 2024540008 A5 JP2024540008 A5 JP 2024540008A5 JP 2024525036 A JP2024525036 A JP 2024525036A JP 2024525036 A JP2024525036 A JP 2024525036A JP 2024540008 A5 JP2024540008 A5 JP 2024540008A5
Authority
JP
Japan
Prior art keywords
piperazine
amino
pyrrolidine
chloro
sulfonylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525036A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540008A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/079506 external-priority patent/WO2023072794A1/en
Publication of JP2024540008A publication Critical patent/JP2024540008A/ja
Publication of JP2024540008A5 publication Critical patent/JP2024540008A5/ja
Pending legal-status Critical Current

Links

JP2024525036A 2021-10-26 2022-10-24 細菌感染症の処置のためのピペラジニルスルホニルアリール化合物 Pending JP2024540008A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2021126369 2021-10-26
CNPCT/CN2021/126369 2021-10-26
PCT/EP2022/079506 WO2023072794A1 (en) 2021-10-26 2022-10-24 Piperazinylsulfonylaryl compounds for treatment of bacterial infections

Publications (2)

Publication Number Publication Date
JP2024540008A JP2024540008A (ja) 2024-10-31
JP2024540008A5 true JP2024540008A5 (https=) 2025-10-31

Family

ID=84361276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525036A Pending JP2024540008A (ja) 2021-10-26 2022-10-24 細菌感染症の処置のためのピペラジニルスルホニルアリール化合物

Country Status (7)

Country Link
US (1) US20250011300A1 (https=)
EP (1) EP4436667B1 (https=)
JP (1) JP2024540008A (https=)
CN (1) CN118201916A (https=)
AR (1) AR127435A1 (https=)
TW (1) TW202325287A (https=)
WO (1) WO2023072794A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024538778A (ja) * 2021-10-12 2024-10-23 エフ. ホフマン-ラ ロシュ アーゲー 細菌感染症の処置のためのスルホニルピペラジニル化合物
CN121127463A (zh) * 2023-04-12 2025-12-12 豪夫迈·罗氏有限公司 用于治疗细菌感染的新颖化合物
CN116942670B (zh) * 2023-07-10 2024-09-27 重庆大学附属肿瘤医院 ChemDiv L676-2179在制备鲍曼不动杆菌AdeABC外排泵抑制剂中的应用
WO2025231273A1 (en) * 2024-05-02 2025-11-06 Arrepath, Inc. Antibacterial compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031443A1 (en) * 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety

Similar Documents

Publication Publication Date Title
JP2024540008A5 (https=)
US11591336B2 (en) Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
JP7654071B2 (ja) 複素環スピロ化合物及び使用方法
JP2025535046A (ja) Kras g12c変異タンパク質の複素環阻害剤及びその使用
AU2023356614A1 (en) Heterocyclic inhibitors of kras g12c mutant proteins and uses thereof
CA2900855C (en) Aminopyrimidinyl compounds
RU2708395C2 (ru) Первичные карбоксамиды в качестве ингибиторов bтk
WO2024238574A1 (en) Cdk inhibitor compounds
HRP20190763T1 (hr) Spojevi pirazina za liječenje zaraznih bolesti
JP2019535689A5 (https=)
JP2015500332A5 (https=)
JP2014525453A5 (https=)
JP2016500073A5 (https=)
KR20140107421A (ko) Pi3k의 활성 또는 기능의 억제제의 용도
CN102791713A (zh) 咪唑并[1,2-a]吡嗪衍生物及其预防或治疗神经病、精神病和代谢性障碍和疾病的用途
AU2015249753A1 (en) Substituted [1,2,4] triazolo [1,5-a] pyrimidin-7-yl compounds as PDE2 inhibitors
TW201546070A (zh) 4-氮雜吲哚衍生物
JP2019530739A5 (https=)
CN115413275A (zh) 取代的1,1,-联苯化合物及其使用方法
TW202115075A (zh) 咪唑并[1,2-a]吡啶基衍生物及其在疾病治療中之用途
TW202116753A (zh) 以噌啉作為hpk1的抑制劑
JP2015527399A5 (https=)
JP2020510621A (ja) Gaba a alpha5 pamとしての新規イソキサゾリルエーテル誘導体
US20140323468A1 (en) Aldosterone synthase inhibitors
US20240174674A1 (en) Nitrogen-containing polycyclic fused ring compound, pharmaceutical composition thereof, preparation method therefor, and use thereof